Bladder cancer

UPDATED --- Handling AEs of targeted therapies for metastatic UCa

Last updated: 11.09.2024

Solve cases and receive feedback

Case 1 - mUCa, grade 2 pneumonitis while on IO

Case 2 - mUCa, grade 2 central serous chorioretinopathy while on targeted therapy

Case 3 - mUCa, steroids after IO-related AE

Case 4 - mUCa, grade 2 peripheral neuropathy while on EV

Case 5 - mUCa, ocular symptoms resolved after erdafitinib withheld

Case 6 - mUCa, grade 2 colitis while on IO

Case 7 - mUCa, grade 3 pneumonitis while on IO

Case 8 - mUCa, grade 2 maculopapular rash while on EV + pembrolizumab

Case 9 - mUCa, grade 3 colitis while on IO

Follow a course and earn CME credits

Earn CME credits by running a case series and completing an assessment. Many topics available for various disease areas. And all for free!

Start a course